Announcement no. 33/2025 Interim report Q2 2025 22 July 2025 COPENHAGEN, Denmark, July 22, 2025 /PRNewswire/ -- Sveinn Sölvason, President and CEO, comments: "Sales in Q2 2025 amounted to USD 232 million, representing 7% reported growth, of which 5% was organic. Growth was strong in the...
Hence then, the article about embla medical hf interim report q2 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Embla Medical hf: Interim Report Q2 2025 )
Also on site :
- Menu-Order-AI Launches on Google Play Store, Expanding Global Access to Its Real-Time GLP-1 Dining Companion
- Bitmine pubblica il messaggio del nuovo presidente in cui spiega perché gli azionisti dovrebbero votare SÌ per approvare l'emendamento per aumentare le azioni autorizzate
- Algorized and KUKA Redefine Robot Safety at CES 2026: The First Robot with "Intuition"